Cargando…
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
Cancer immunotherapy combinations have recently been shown to improve the overall survival of advanced mesotheliomas, especially for patients responding to those treatments. We aimed to characterize the biological correlates of malignant pleural mesotheliomas’ primary resistance to immunotherapy and...
Ejemplares similares
-
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers
por: Baldini, Capucine, et al.
Publicado: (2022) -
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
por: Rouanne, Mathieu, et al.
Publicado: (2022) -
Synergizing liver systemic treatments with interventional oncology: friend or foe?
por: Jost, Raphaël, et al.
Publicado: (2022) -
Protumor immunity and breast cancer development
por: Coussens, LM
Publicado: (2009) -
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
por: Silvin, Aymeric, et al.
Publicado: (2020)